Basilea Pharmaceutica AG (OTCMKTS:BPMUF – Get Free Report) was the target of a large growth in short interest in April. As of April 30th, there was short interest totaling 4,577 shares, a growth of 1,702.0% from the April 15th total of 254 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average trading volume of 3 shares, the days-to-cover ratio is currently 1,525.7 days.
Basilea Pharmaceutica Price Performance
OTCMKTS:BPMUF opened at $69.00 on Wednesday. Basilea Pharmaceutica has a fifty-two week low of $57.70 and a fifty-two week high of $74.00. The company has a debt-to-equity ratio of 0.59, a quick ratio of 4.68 and a current ratio of 5.11. The company’s 50-day simple moving average is $70.35 and its 200-day simple moving average is $67.01.
About Basilea Pharmaceutica
Basilea Pharmaceutica AG is a Swiss biopharmaceutical company headquartered in Basel, specializing in the development and commercialization of innovative treatments for hospital‐treated diseases. The company’s research is focused primarily on anti‐infectives and oncology, with a portfolio that spans both marketed products and early‐ to late‐stage pipeline candidates. Basilea leverages medicinal chemistry expertise to address critical medical needs in fungal infections, bacterial infections and cancer.
Among its lead products is isavuconazole, a broad‐spectrum antifungal agent marketed under the trade name Cresemba.
Recommended Stories
- Five stocks we like better than Basilea Pharmaceutica
- Navitas Breaks Out on India Deal, Validating High-Power AI Pivot
- Navy Catalyst Ignites Odysight’s Growth Engine
- AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?
- Axon Surged After Earnings and Is Still Down Over 50% From Highs
Receive News & Ratings for Basilea Pharmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basilea Pharmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.
